Last July, we suggested that a “Bond Replacement” covered call investment in IBM looked attractive. Since then, we have written several articles on IBM and have now updated our model with the most recently-published financial statement data. Our thesis hasn’t changed on IBM, and we still see an attractive investment opportunity. Take a look at our newly-published Tear Sheet and read through our detailed valuation note to get the specifics!
Learn More! Contact Us Today!